Medium-term open label trial of L-carnitine in Rett syndrome

Brain and Development

Volumn 23, Issue SUPPL. 1, 2001, Pages

  Ellaway, Carolyn J ^a,b   Peat, Jennifer ^a   Williams, Katrina ^a,b   Leonard, Helen ^c   Christodoulou, John ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

L carnitine; Rett syndrome; Treatment

Indexed keywords

CARNITINE;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INTERPERSONAL COMMUNICATION; RANDOMIZED CONTROLLED TRIAL; RETT SYNDROME; SCHOOL CHILD; SLEEP DISORDER;

ADOLESCENT; ADULT; APRAXIAS; CARNITINE; CHILD; FEMALE; HEALTH SURVEYS; HUMANS; QUESTIONNAIRES; RECOVERY OF FUNCTION; RESPIRATION DISORDERS; RETT SYNDROME; SLEEP DISORDERS; SPEECH DISORDERS; TREATMENT OUTCOME;

EID: 0035197320     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(01)00346-1     Document Type: Conference Paper

References (9)

1. Rett syndrome: randomised controlled trial of L-carnitine
2. The prevalence and incidence of Rett syndrome in Australia
3. The hand apraxia scale
4. Evaluation of commercial accelerometer (Tritrac-R3D) to measure energy expenditure during ambulation
5. First prenatal diagnosis of the carnitine transporter defect
6. Carnitine deficiency states
7. Energy on demand